| Overview |
| bsm-61309r-percp-cy7-100ul |
| Delta Opioid Receptor Recombinant Antibody, PerCP-Cy7 Conjugated |
| WB |
| Human, Mouse, Rat |
| Specifications |
| PerCP-Cy7 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human DOR 1 |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 4985 |
| P41143 |
| Cell membrane |
| Delta type opioid receptor; Delta type opioid receptor DOR1; DOR 1; mDOR; Nbor; Opioid receptor delta 1; OPRD 1. |
| G-protein coupled receptor that functions as a receptor for endogenous enkephalins and for a subset of other opioids. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Signaling leads to the inhibition of adenylate cyclase activity. Inhibits neurotransmitter release by reducing calcium ion currents and increasing potassium ion conductance. |
| Application Dilution |
| WB |
1:300-5000 |
Powered by Bioz